AU2004271744B2 - Use of ciclesonide for the treatment of respiratory diseases - Google Patents

Use of ciclesonide for the treatment of respiratory diseases Download PDF

Info

Publication number
AU2004271744B2
AU2004271744B2 AU2004271744A AU2004271744A AU2004271744B2 AU 2004271744 B2 AU2004271744 B2 AU 2004271744B2 AU 2004271744 A AU2004271744 A AU 2004271744A AU 2004271744 A AU2004271744 A AU 2004271744A AU 2004271744 B2 AU2004271744 B2 AU 2004271744B2
Authority
AU
Australia
Prior art keywords
ciclesonide
use according
dion
oxy
dose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU2004271744A
Other languages
English (en)
Other versions
AU2004271744A1 (en
Inventor
Thomas Bethke
Renate Engelstaetter
Wilhelm Wurst
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Covis Pharma GmbH
Original Assignee
Covis Pharma GmbH
Covis Pharma BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34312429&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU2004271744(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Covis Pharma GmbH, Covis Pharma BV filed Critical Covis Pharma GmbH
Publication of AU2004271744A1 publication Critical patent/AU2004271744A1/en
Assigned to NYCOMED GMBH reassignment NYCOMED GMBH Request for Assignment Assignors: ALTANA PHARMA AG
Application granted granted Critical
Publication of AU2004271744B2 publication Critical patent/AU2004271744B2/en
Assigned to TAKEDA GMBH reassignment TAKEDA GMBH Request to Amend Deed and Register Assignors: NYCOMED GMBH
Assigned to TAKEDA GMBH reassignment TAKEDA GMBH Request to Amend Deed and Register Assignors: TAKEDA GMBH
Assigned to ASTRAZENECA AB reassignment ASTRAZENECA AB Request for Assignment Assignors: TAKEDA GMBH
Assigned to COVIS PHARMA B.V. reassignment COVIS PHARMA B.V. Request for Assignment Assignors: ASTRAZENECA AB
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
AU2004271744A 2003-09-16 2004-09-15 Use of ciclesonide for the treatment of respiratory diseases Expired AU2004271744B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US50298403P 2003-09-16 2003-09-16
US60/502,984 2003-09-16
PCT/EP2004/052172 WO2005025578A1 (en) 2003-09-16 2004-09-15 Use of ciclesonide for the treatment of respiratory diseases

Publications (2)

Publication Number Publication Date
AU2004271744A1 AU2004271744A1 (en) 2005-03-24
AU2004271744B2 true AU2004271744B2 (en) 2010-07-29

Family

ID=34312429

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2004271744A Expired AU2004271744B2 (en) 2003-09-16 2004-09-15 Use of ciclesonide for the treatment of respiratory diseases

Country Status (11)

Country Link
US (4) US8371292B2 (cg-RX-API-DMAC7.html)
EP (1) EP1670482B2 (cg-RX-API-DMAC7.html)
JP (2) JP5618452B2 (cg-RX-API-DMAC7.html)
AU (1) AU2004271744B2 (cg-RX-API-DMAC7.html)
CA (1) CA2538419C (cg-RX-API-DMAC7.html)
DK (1) DK1670482T4 (cg-RX-API-DMAC7.html)
ES (1) ES2452691T5 (cg-RX-API-DMAC7.html)
HR (1) HRP20140257T4 (cg-RX-API-DMAC7.html)
PL (1) PL1670482T5 (cg-RX-API-DMAC7.html)
PT (1) PT1670482E (cg-RX-API-DMAC7.html)
WO (1) WO2005025578A1 (cg-RX-API-DMAC7.html)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2508692C (en) * 2002-12-12 2012-04-03 Altana Pharma Ag Combination medicament
JP5618452B2 (ja) 2003-09-16 2014-11-05 タケダ ゲゼルシャフト ミット ベシュレンクテル ハフツングＴａｋｅｄａ ＧｍｂＨ 呼吸器疾患の治療のためのシクレソニドの使用
PE20050941A1 (es) * 2003-12-16 2005-11-08 Nycomed Gmbh Suspensiones acuosas de ciclesonida para nebulizacion
US20070185067A1 (en) * 2004-02-27 2007-08-09 Altana Pharma Ag Ciclesonide and glycopyrronium combination
AU2005235384B2 (en) * 2004-04-20 2010-09-09 Covis Pharma B.V. Use of ciclesonide for the treatment of respiratory diseases in a smoking patient
CA2637815A1 (en) * 2006-02-08 2007-08-16 Sicor Inc. Crystalline forms of ciclesonide
NZ584876A (en) * 2007-10-25 2012-06-29 Merck Frosst Canada Ltd Inhalation compositions comprising montelukast acid and a pde-4-inhibitor or an inhaled corticosteroid
WO2010104187A1 (ja) * 2009-03-09 2010-09-16 三笠製薬株式会社 ステロイド化合物
CA2844944A1 (en) 2011-08-18 2013-02-21 Takeda Gmbh Pharmaceutical aerosol product for administration by oral or nasal inhalation
ES2909039T3 (es) 2012-12-21 2022-05-05 Boehringer Ingelheim Vetmedica Gmbh Formulación farmacéutica que comprende ciclesonida
US20140179651A1 (en) 2012-12-21 2014-06-26 Boehringer Ingelheim Vetmedica Gmbh Ciclesonide for the treatment of airway disease in horses
HUE051527T2 (hu) 2014-06-18 2021-03-01 Boehringer Ingelheim Vetmedica Gmbh Muszkarin-antagonisták és kombinációik légúti betegség lovakban történõ kezelésére
EP3432954B1 (en) * 2016-03-24 2022-04-20 Services Medicaux Arnold et Joan Zidulka Inc. Device for delivering particles in the upper respiratory tract
AU2017274442B2 (en) 2016-06-02 2021-08-19 Abbvie Inc. Glucocorticoid receptor agonist and immunoconjugates thereof
PT3658192T (pt) 2017-12-01 2021-06-25 Abbvie Inc Agonista recetor de glucocorticóide e imunoconjugados do mesmo
WO2025085662A1 (en) 2023-10-17 2025-04-24 Vanderbilt University Compounds for tocolytic use

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6264923B1 (en) * 1998-05-13 2001-07-24 3M Innovative Properties Company Medicinal aerosol formulation of ciclesonide and related compounds

Family Cites Families (84)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0039123B1 (en) * 1980-02-27 1984-10-03 TATE & LYLE PUBLIC LIMITED COMPANY Crystalline glucose and process for its production
US4816445A (en) * 1984-06-21 1989-03-28 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Crystalline alpha-maltose
JP2518646B2 (ja) * 1987-05-29 1996-07-24 株式会社 林原生物化学研究所 マルト−ス粉末の製造方法
GB8828477D0 (en) 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
US5133974A (en) * 1989-05-05 1992-07-28 Kv Pharmaceutical Company Extended release pharmaceutical formulations
DE407028T1 (de) 1989-05-31 1994-03-17 Fisons Plc Medikament und Inhalationsvorrichtung dafür.
GB8921222D0 (en) 1989-09-20 1989-11-08 Riker Laboratories Inc Medicinal aerosol formulations
SE8903914D0 (sv) 1989-11-22 1989-11-22 Draco Ab Oral composition for the treatment of inflammatory bowel diseases
IL97065A (en) 1990-02-02 1994-01-25 Fisons Plc Repellent preparations for aerosol
DE4003272A1 (de) 1990-02-03 1991-08-08 Boehringer Ingelheim Kg Neue treibgasmischungen und ihre verwendung in arzneimittelzubereitungen
US6536427B2 (en) * 1990-03-02 2003-03-25 Glaxo Group Limited Inhalation device
WO1991014422A1 (en) 1990-03-23 1991-10-03 Minnesota Mining And Manufacturing Company The use of soluble fluorosurfactants for the preparation of metered-dose aerosol formulations
US5178866A (en) * 1990-03-23 1993-01-12 Alza Corporation Dosage form for delivering drug to the intestine
GR1001529B (el) 1990-09-07 1994-03-31 Elmuquimica Farm Sl Μέ?οδος για την λήψη νέων 21-εστέρων της 16-17-ακετάλης της πρ να-1,4-διενο-3,20-διόνης.
US5434304A (en) * 1990-09-26 1995-07-18 Aktiebolaget Astra Process for preparing formoterol and related compounds
CA2094266C (en) 1990-10-18 1999-06-01 Robert K. Schultz Aerosol formulations of beclomethasone-17,21-dipropionate
US5290539A (en) 1990-12-21 1994-03-01 Minnesota Mining And Manufacturing Company Device for delivering an aerosol
AU650953B2 (en) 1991-03-21 1994-07-07 Novartis Ag Inhaler
US6866839B2 (en) * 1991-04-05 2005-03-15 Sepracor Inc. Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterol
US5795564A (en) * 1991-04-05 1998-08-18 Sepracor, Inc. Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterol
ZA924164B (en) * 1991-06-10 1993-02-24 Schering Corp Non-chlorofluorocarbon aerosol formulations
IT1250691B (it) * 1991-07-22 1995-04-21 Giancarlo Santus Composizioni terapeutiche per somministrazione intranasale comprendenti ketorolac.
IL104068A (en) 1991-12-12 1998-10-30 Glaxo Group Ltd Surfactant-free pharmaceutical aerosol formulation comprising 1,1,1,2-tetrafluoroethane or 1,1,1,2,3,3,3-heptafluoro-n- propane as propellant
GB9213874D0 (en) 1992-06-30 1992-08-12 Fisons Plc Process to novel medicament form
GB9306703D0 (en) 1993-03-31 1993-05-26 Fisons Plc Inhalation device
RU2132854C1 (ru) 1993-04-02 1999-07-10 Бик Гульден Ломберг Хемише Фабрик ГмбХ Производные преднизолона, способ их получения и лекарственное средство
US5476411A (en) 1993-07-16 1995-12-19 Henkel Corporation Aqueous composition for wet sanding of dried paint, plastics, and the like
IL111194A (en) 1993-10-08 1998-02-08 Fisons Plc Process for the production of medicament formulations
DE4434629C1 (de) * 1994-09-28 1996-06-27 Byk Gulden Lomberg Chem Fab Zusammensetzungen zur Behandlung von IRDS und ARDS
DE19541689A1 (de) 1994-11-14 1996-05-15 Byk Gulden Lomberg Chem Fab Kombinationsarzneimittel
JPH11509434A (ja) 1995-04-14 1999-08-24 グラクソ、ウェルカム、インコーポレーテッド サルメテロール用計量投与用吸入器
US5811388A (en) * 1995-06-07 1998-09-22 Cibus Pharmaceutical, Inc. Delivery of drugs to the lower GI tract
CA2224517A1 (en) * 1995-06-12 1996-12-27 G.D. Searle & Co. Compositions comprising a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor
AU7095296A (en) * 1995-09-26 1997-04-17 Takeda Chemical Industries Ltd. Phosphorylamides, their preparation and use
DE19635498A1 (de) 1996-09-03 1998-03-26 Byk Gulden Lomberg Chem Fab Verfahren zur Epimerenanreicherung
US6599927B2 (en) * 1996-10-11 2003-07-29 Astrazeneca Ab Use of an H+, K+-ATPase inhibitor in the treatment of Widal's Syndrome
SE9603725D0 (sv) 1996-10-11 1996-10-11 Astra Ab New teatment
FR2754712B1 (fr) * 1996-10-17 1999-09-03 Merck Sharp Dohme Chibret Lab Compositions ophtalmiques
US6613795B2 (en) * 1996-11-11 2003-09-02 Christian Noe Enantiomerically pure basic arylcycloalkylhydroxycarboxylic esters, processes for their preparation and their use in medicaments
US6040344A (en) 1996-11-11 2000-03-21 Sepracor Inc. Formoterol process
SE9700135D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
US20020111495A1 (en) * 1997-04-04 2002-08-15 Pfizer Inc. Nicotinamide acids, amides, and their mimetics active as inhibitors of PDE4 isozymes
US6120752A (en) * 1997-05-21 2000-09-19 3M Innovative Properties Company Medicinal aerosol products containing formulations of ciclesonide and related steroids
GB2329939A (en) * 1997-06-26 1999-04-07 Glaxo Group Ltd Self-lubricating valve stem for aerosol containers
US6470894B2 (en) 1997-09-19 2002-10-29 Thione International, Inc. Glutathione, green tea, grape seed extract to neutralize tobacco free radicals
SE9704186D0 (sv) 1997-11-14 1997-11-14 Astra Ab New composition of matter
WO1999031073A1 (en) * 1997-12-15 1999-06-24 Yamanouchi Pharmaceutical Co., Ltd. Novel pyrimidine-5-carboxamide derivatives
SE9801368D0 (sv) 1998-04-20 1998-04-20 Astra Ab New use
TWI243687B (en) * 1998-04-21 2005-11-21 Teijin Ltd Pharmaceutical composition for application to mucosa
US6241969B1 (en) * 1998-06-26 2001-06-05 Elan Corporation Plc Aqueous compositions containing corticosteroids for nasal and pulmonary delivery
ES2234266T3 (es) * 1998-07-24 2005-06-16 Jago Research Ag Formulaciones medicas para aerosoles.
CN1150890C (zh) * 1998-08-04 2004-05-26 杰格研究股份公司 药用气溶胶制剂
ATE231862T1 (de) 1998-09-23 2003-02-15 Altana Pharma Ag Tetrahydropyridoether
NZ511527A (en) * 1998-11-13 2002-10-25 Jago Res A Dry powder for inhalation
US6352152B1 (en) 1998-12-18 2002-03-05 Smithkline Beecham Corporation Method and package for storing a pressurized container containing a drug
US6397838B1 (en) * 1998-12-23 2002-06-04 Battelle Pulmonary Therapeutics, Inc. Pulmonary aerosol delivery device and method
US6124268A (en) * 1999-02-17 2000-09-26 Natreon Inc. Natural antioxidant compositions, method for obtaining same and cosmetic, pharmaceutical and nutritional formulations thereof
US6302331B1 (en) * 1999-04-23 2001-10-16 Battelle Pulmonary Therapeutics, Inc. Directionally controlled EHD aerosol sprayer
ATE336301T1 (de) * 1999-04-23 2006-09-15 Ventaira Pharmaceuticals Inc Elektrostatisches versprühen mit transfer- hoher masse
JP2001048807A (ja) 1999-08-04 2001-02-20 Wakamoto Pharmaceut Co Ltd 難溶性薬物を水に溶解してなる製剤
DE19947234A1 (de) 1999-09-30 2001-04-05 Asta Medica Ag Neue Kombination von Loteprednol und Antihistaminika
AR026072A1 (es) * 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica que contiene ciclesonida para aplicacion a la mucosa
AR026073A1 (es) 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica acuosa que contiene ciclesonida
GB0002336D0 (en) 2000-02-01 2000-03-22 Glaxo Group Ltd Medicaments
US7585847B2 (en) * 2000-02-03 2009-09-08 Coley Pharmaceutical Group, Inc. Immunostimulatory nucleic acids for the treatment of asthma and allergy
GB0009607D0 (en) 2000-04-18 2000-06-07 Glaxo Group Ltd Medical compositions
GB0012261D0 (en) 2000-05-19 2000-07-12 Astrazeneca Ab Novel process
GB0015043D0 (en) 2000-06-21 2000-08-09 Glaxo Group Ltd Medicament dispenser
TWI227231B (en) 2000-07-12 2005-02-01 Novartis Ag 4-benzoyl-piperidine derivatives for treating conditions mediated by CCR-3
FI20002177A0 (fi) 2000-10-02 2000-10-02 Orion Yhtymae Oyj Uusi yhdistelmä astman hoitoon
CZ2003983A3 (cs) 2000-10-09 2003-09-17 3M Innovative Properties Company Léčivé aerosolové přípravky
DE10062712A1 (de) * 2000-12-15 2002-06-20 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Corticosteroiden
US20020183292A1 (en) * 2000-10-31 2002-12-05 Michel Pairet Pharmaceutical compositions based on anticholinergics and corticosteroids
WO2002038155A1 (en) * 2000-11-07 2002-05-16 Merck & Co., Inc. Method of treatment with a combination of a pde4 inhibitor and a leukotriene antagonist
WO2002051483A1 (en) * 2000-12-22 2002-07-04 Glaxo Group Limited Metered dose inhaler for salmeterol xinafoate
WO2003006310A1 (fr) 2001-07-13 2003-01-23 Tfe Techniques Et Fabrications Electroniques Dispositif destine a indiquer acoustiquement a un plongeur equipe d'un scaphandre la pression de gaz de respiration dans le reservoir et/ou la pression hydrostatique
AU2002350622B2 (en) * 2001-10-24 2006-09-14 Pari Pharma Gmbh Kit for the preparation of a pharmaceutical composition
ATE402091T1 (de) 2001-11-17 2008-08-15 Aventis Pharma Ltd Pharmazeutisches produkt und verfahren mit adsorber
US20050020637A1 (en) * 2001-11-19 2005-01-27 Wolfgang-Alexander Simon Agents for the treatment of airway disorders
ITMI20020808A1 (it) * 2002-04-17 2003-10-17 Chiesi Farma Spa Procedimento per la preparazione di una sospensione sterile di particelle di beclometasone dipropionato da somministrare per inalazione
MXPA04012756A (es) * 2002-07-02 2005-03-23 Altana Pharma Ag Suspension acuosa esteril que contiene ciclesonida.
CA2508692C (en) 2002-12-12 2012-04-03 Altana Pharma Ag Combination medicament
EP1452179A1 (en) 2003-02-27 2004-09-01 CHIESI FARMACEUTICI S.p.A. Novel medicament combination of a highly potent long-lasting beta2-agonist and a corticosteroid
JP5618452B2 (ja) 2003-09-16 2014-11-05 タケダ ゲゼルシャフト ミット ベシュレンクテル ハフツングＴａｋｅｄａ ＧｍｂＨ 呼吸器疾患の治療のためのシクレソニドの使用

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6264923B1 (en) * 1998-05-13 2001-07-24 3M Innovative Properties Company Medicinal aerosol formulation of ciclesonide and related compounds

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Dent, Gordon "Ciclesonide" Current opinion in investigational drugs, Vol 3 No 1 2002 *
Mealy N E et al "Ciclesonide: Treatment of allergic rhinitis antiallergy / antiasthmatic" Drugs of the Future. Vol 26 No 11 November 2001 *

Also Published As

Publication number Publication date
US20190290661A1 (en) 2019-09-26
PL1670482T3 (pl) 2014-05-30
US20070025923A1 (en) 2007-02-01
HRP20140257T1 (hr) 2014-04-25
HRP20140257T4 (hr) 2022-11-25
ES2452691T3 (es) 2014-04-02
US8371292B2 (en) 2013-02-12
JP2007505829A (ja) 2007-03-15
US20130143849A1 (en) 2013-06-06
EP1670482B2 (en) 2022-06-29
EP1670482A1 (en) 2006-06-21
PT1670482E (pt) 2014-03-12
DK1670482T4 (da) 2022-08-22
DK1670482T3 (en) 2014-03-17
PL1670482T5 (pl) 2022-10-03
CA2538419C (en) 2012-07-03
WO2005025578A1 (en) 2005-03-24
EP1670482B1 (en) 2013-12-25
US20220241297A1 (en) 2022-08-04
ES2452691T5 (es) 2022-09-14
CA2538419A1 (en) 2005-03-24
JP2012197306A (ja) 2012-10-18
JP5618452B2 (ja) 2014-11-05
AU2004271744A1 (en) 2005-03-24

Similar Documents

Publication Publication Date Title
US20220241297A1 (en) Use of ciclesonide for the treatment of respiratory diseases
US20060293293A1 (en) Salmeterol and ciclesonide combination
BRPI0308274B1 (pt) formulação de formoterol superfino
US20080027034A1 (en) Ciclesonide and Syk Inhibitor Combination and Method of Use Thereof
US20070185067A1 (en) Ciclesonide and glycopyrronium combination
TW201119644A (en) Pharmaceutical aerosol formulations of formoterol and beclometasone dipropionate
AU2005235384B2 (en) Use of ciclesonide for the treatment of respiratory diseases in a smoking patient
US8435497B2 (en) Formoterol of and ciclesonide combination
WO2006097458A1 (en) Novel combination

Legal Events

Date Code Title Description
TC Change of applicant's name (sec. 104)

Owner name: NYCOMED GMBH

Free format text: FORMER NAME: ALTANA PHARMA AG

FGA Letters patent sealed or granted (standard patent)
DA2 Applications for amendment section 104

Free format text: THE NATURE OF THE AMENDMENT IS: AMEND THE PATENTEE TO READ TAKEDA GMBH .

PC Assignment registered

Owner name: ASTRAZENECA AB

Free format text: FORMER OWNER WAS: TAKEDA GMBH

PC Assignment registered

Owner name: COVIS PHARMA B.V.

Free format text: FORMER OWNER(S): ASTRAZENECA AB

MK14 Patent ceased section 143(a) (annual fees not paid) or expired